About this trial
The purpose of this study is to evaluate the efficacy and safety of IBD stent of Shenzhen Xianjian Company and IBE stent of American Gore company in the treatment of abdominal aortic aneurysm/iliac aneurysm reconstruction of internal iliac artery
Eligibility criteria
Qualifiers
Patients with iliac aneurysms combined with or without abdominal aortic aneurysms and internal iliac arteries reconstructed with iliac branch stents;
Male or female ≥18 years old, ≤85 years old;
Life expectancy > 2 years;
The patient signed the informed consent voluntarily and was able to comply with the treatment plan and complete the follow-up and examination as planned.
Disqualifiers
Fungal or ruptured aneurysm
Known complications of thoracic aortic aneurysm require interventional treatment
American Association of Anesthesiologists (ASA) Grade V
Creatinine > 2.5mg/dL or dialysis patients
Trial design
Treatments tested in this trial
- IBD stent of Shenzhen Xianjian Company and IBE stent of American Gore company